Pursuant to Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Kimia Biosciences has informed that the Company received the intimation letter from Registrar & Transfer Agent, Beetal Financial Services regarding the request received for issuance of duplicate share certificates, the details of which are enclosed. Pursuant to SEBI Circular No. SEBI/MIRSD/MIRSD_RTAMB/P/2022/8 dated January 25, 2022 a letter of confirmation will be issued to the securities holder/ claimant upon completion of necessary procedures regarding duplicate share certificates.
The above information is a part of company’s filings submitted to BSE.
